期刊
JOURNAL OF NEUROCHEMISTRY
卷 105, 期 5, 页码 1979-1995出版社
WILEY
DOI: 10.1111/j.1471-4159.2008.05288.x
关键词
dNA affinity chromatography; DNA-binding proteins; enhanceosome; intronic enhancer; mass spectrometry; multi-protein complex; myelin proteolipid protein gene; proteomics
资金
- NINDS NIH HHS [NS037821, NS047546, P30 NS047546, R01 NS037821] Funding Source: Medline
The myelin proteolipid protein gene (Plp1) encodes the most abundant protein found in CNS myelin, accounting for nearly one-half of the total protein. Its expression in oligodendrocytes is developmentally regulated - peaking during the active myelination period of CNS development. Previously, we have identified a novel enhancer (designated ASE) in intron 1 DNA that appears to be important in mediating the surge of Plp1 gene activity during the active myelination period. Evidence suggests that the ASE participates in the formation of a specialized multi-protein/DNA complex called an enhanceosome. The current study describes an optimized, five-step, DNA affinity chromatography purification procedure to purify nuclear proteins from mouse brain that bind to the 85-bp ASE sequence, specifically. Electrophoretic mobility shift assay analysis demonstrated that specific DNA-binding activity was retained throughout the purification procedure, resulting in concomitant enrichment of nucleoprotein complexes. Identification of the purported regulatory factors was achieved through mass spectrometry analysis and included over 20 sequence-specific DNA-binding proteins. Supplementary western blot analyses to determine which of these sequence-specific factors are present in oligodendrocytes, and their developmental and regional expression in whole brain, suggest that Pur alpha and Pur beta rank highest among the candidate factors as constituents of the multi-protein complex formed on the ASE.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据